Turning numbers into action: optimising care in T2DM and CKD
Seminar
•
AstraZeneca
About the CPD course
Developed to support HCPs in primary care to better understand and apply the learnings from clinical trials reporting into their day-to-day practice. Spanning trial design; inclusion criteria; endpoints; reporting of absolute risk reduction; relative risk reduction; Numbers Need to Treat; and much more; this presentation contextualises clinical trial information through the lens of a key trial in chronic kidney disease relevant to primary care physicians’ practice.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines.
Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.
